Skip to content

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

A Randomized Controlled Study to Evaluate the Safety and Effectiveness of Boston Scientific Spinal Cord Stimulation (SCS) Systems in the Treatment of Chronic Low Back and/or Leg Pain With No Prior Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04676022
Acronym
SOLIS
Enrollment
241
Registered
2020-12-19
Start date
2021-03-26
Completion date
2025-02-21
Last updated
2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Spinal Cord Stimulation

Brief summary

To evaluate the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities compared to Conventional Medical Management (CMM) in patients with chronic low back and/or leg pain who have not undergone spinal surgery when using the Boston Scientific WaveWriter SCS Systems.

Interventions

DEVICEWaveWriter

To receive Spinal Cord Stimulation programming

OTHERConventional Medical Managament

To receive conventional medical management

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Chronic low back pain, with or without leg pain, for at least 6 months * Received at least 90 days of documented pain management care to address the primary pain complaint, prior to Screening (e.g. medication, physical therapy) * If female of childbearing potential: not pregnant, as evidenced by a negative pregnancy test at Screening * Subject signed a valid, IRB-approved informed consent form (ICF) provided in English Key

Exclusion criteria

* Primary pain complaint of vascular origin (e.g. peripheral vascular disease) * Require implantation of lead(s) in the cervical epidural space * Significant cognitive impairment at Screening that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to assess pain intensity * Previous failed spinal cord stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)

Design outcomes

Primary

MeasureTime frameDescription
Responder Rate3 months post-activationProportion of subjects with 50% or greater reduction in overall pain relief

Secondary

MeasureTime frameDescription
Change in Disability (Oswestry Disability Index)3-Months post activationChange in Disability (Oswestry Disability Index). The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Countries

United States

Participant flow

Recruitment details

241 subjects provided informed consent.

Pre-assignment details

After subjects were consented and enrolled, they were evaluated per study eligibility criteria. Only those who met criteria proceeded to randomization.

Participants by arm

ArmCount
Randomized to Spinal Cord Stimulation (SCS) Treatment Activated
Baseline demographics and clinical characteristics for subjects in the SCS arm
79
Randomized to Conventional Medical Management (CMM) Treatment Activated
Baseline demographics and clinical characteristics for subjects in the CMM arm
68
Total147

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyAdverse Event201
Overall StudyLost to Follow-up110
Overall StudyPhysician Decision201
Overall StudyScreen Failure/1185
Overall StudyVarious reasons (moved, no longer meets criteria, visit not done etc.)711
Overall StudyWill not move forward with permanent implant600
Overall StudyWithdrawal by Subject316

Baseline characteristics

CharacteristicRandomized to Spinal Cord Stimulation (SCS) Treatment ActivatedRandomized to Conventional Medical Management (CMM) Treatment ActivatedTotal
Age, Continuous57.3 years
STANDARD_DEVIATION 12.1
61.0 years
STANDARD_DEVIATION 11.9
59.0 years
STANDARD_DEVIATION 12.1
Average low back pain (VRS)7.5 units on a scale
STANDARD_DEVIATION 1
7.6 units on a scale
STANDARD_DEVIATION 0.9
7.6 units on a scale
STANDARD_DEVIATION 0.9
Average overall pain (VRS)7.5 units on a scale
STANDARD_DEVIATION 0.9
7.5 units on a scale
STANDARD_DEVIATION 1
7.5 units on a scale
STANDARD_DEVIATION 0.9
Duration of Low Back Pain11.5 years
STANDARD_DEVIATION 10.4
12.9 years
STANDARD_DEVIATION 11.5
12.2 years
STANDARD_DEVIATION 10.9
Oswestry Disability Index (ODI) Summary Score54.4 units on a scale
STANDARD_DEVIATION 8.5
54.4 units on a scale
STANDARD_DEVIATION 9.4
54.4 units on a scale
STANDARD_DEVIATION 8.9
Race/Ethnicity, Customized
Race and Ethnicity : American Indian or Alaska native
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Race and Ethnicity : Black, of African heritage
6 Participants3 Participants9 Participants
Race/Ethnicity, Customized
Race and Ethnicity : Caucasian
72 Participants62 Participants134 Participants
Race/Ethnicity, Customized
Race and Ethnicity : Hispanic or Latino
0 Participants3 Participants3 Participants
Race/Ethnicity, Customized
Race and Ethnicity : Not disclosed
1 Participants0 Participants1 Participants
Region of Enrollment
United States
79 participants68 participants147 participants
Sex: Female, Male
Female
55 Participants43 Participants98 Participants
Sex: Female, Male
Male
24 Participants25 Participants49 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 791 / 68
other
Total, other adverse events
9 / 794 / 68
serious
Total, serious adverse events
8 / 791 / 68

Outcome results

Primary

Responder Rate

Proportion of subjects with 50% or greater reduction in overall pain relief

Time frame: 3 months post-activation

Population: Intent to Treat population

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Spinal Cord StimulationResponder Rate51 Participants
Conventional Medical ManagementResponder Rate5 Participants
Secondary

Change in Disability (Oswestry Disability Index)

Change in Disability (Oswestry Disability Index). The Oswestry Disability Index (ODI) is a validated questionnaire of pain-related disability with total score on a scale of 0 (no disability) to 100 (complete disability). Categories for ODI total score are 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). The published minimally clinically important difference for change in ODI is 10 points.

Time frame: 3-Months post activation

Population: Intent to treat population

ArmMeasureValue (MEAN)Dispersion
Spinal Cord StimulationChange in Disability (Oswestry Disability Index)-27.5 score on a scaleStandard Deviation 15.9
Conventional Medical ManagementChange in Disability (Oswestry Disability Index)-7.2 score on a scaleStandard Deviation 9.9

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026